pharmaceuticals
pharmaceuticals Articles
Shares of Ariad Pharmaceuticals saw a modest gain early Monday after the company announced a recent FDA decision.
Published:
Last Updated:
Opexa Therapeutics Inc. (NASDAQ: OPXA) shares were in free fall Friday morning after the company reported results from its mid-stage trial for the treatment of secondary progressive multiple...
Published:
Last Updated:
AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.
Published:
Last Updated:
Myovant Sciences entered the market near the high end of its expected price range for its initial public offering.
Published:
Last Updated:
Bristol-Myers Squibb Co. (NYSE: BMY) is scheduled to release third-quarter financial results before markets open on Thursday. The consensus estimates from Thomson Reuters are calling for $0.65 in...
Published:
Last Updated:
Ra Pharmaceuticals had a very strong entrance to the market on Wednesday, with shares going out at the top of the expected price range.
Published:
Last Updated:
The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Dipexium Pharmaceuticals Inc. (NASDAQ: DPRX) is watching its shares in free fall on Tuesday after the company announced data from its late-stage trial. The question on everyone’s mind is whether or...
Published:
Last Updated:
Myovant Sciences registered an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price 13 million shares in...
Published:
Last Updated:
Merck is scheduled to release its third-quarter earnings report after before the markets open on Tuesday.
Published:
Last Updated:
Ariad Pharmaceuticals shares were down handily on Monday after JPMorgan downgraded the stock. Also Senator Sanders recently asked about the pricing of its blood cancer drug Iclusig.
Published:
Last Updated:
aTyr Pharma watched its shares climb early on Monday after the company announced that its product candidate Resolaris was granted Fast Track designation by the FDA.
Published:
Last Updated:
Shares of Inovio Pharmaceuticals slid in Monday’s session on news that the FDA placed a clinical hold on a proposed Inovio Phase 3 clinical program.
Published:
Last Updated:
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
Published:
Last Updated:
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
Published:
Last Updated: